Today, during the 2016 UK-China High Level People-to-People Dialogue, the United Kingdom (UK) Secretary of State for Health, Jeremy Hunt, and Chinese Science and Technology Minister, Wang Zhigang, will sign a Memorandum of Understanding to establish a new UK-China Antimicrobial Resistance (AMR) Research and Innovation Collaboration. This Memorandum is the first step towards the establishment of a new Global AMR Innovation Fund. The UK plans to provide up to £10 million between 2018 and 2020 towards joint projects led by UK and Chinese researchers, academics and businesses on the basis of match-funding from the Chinese government and from businesses. The scope and research priorities for this collaboration will...Read more
The European Commission is finalizing a new five-year antimicrobial resistance (AMR) action plan for the region, which will be launched next year. European Public Health Commissioner Vytenis Andriukaitis made a statement on 18 November announcing that, "The European Commission will launch, in 2017, a second action plan building upon and strengthening the work already done and supporting member states in the implementation and monitoring of their national action plans.” The new plan will continue with a One Health approach and there are plans to establish a forum for Member States' national authorities to exchange best practice information and arrange peer reviews of national action plans. For more information,
DRIVE-AB has held its second annual General Assembly Meeting from 17-18 October in Oslo, Norway. The meeting brought consortium partners, hailing from both academic and EFPIA institutions, together from all around the world along with representation from a key stakeholder in the United States, the Duke-Margolis Center for Health Policy. The two-day meeting consisted of a series of plenary discussions and interactive break out sessions where the consortium partners discussed the progress of the project as well as next steps for the final upcoming year. A major point of discussion at the meeting was key upcoming stakeholder engagement activities and the communication of the consortium’s final results as DRIVE-AB...Read more
On 10 October, 2016, DRIVE-AB Communications co-leader Ursula Theuretzbacher presented at a side event to the World Health Summit in Berlin titled, "Global Expert Network Conference on Innovations in Antimicrobial Drug Research and Development", organized by the German government. The presentation, "Strengthening AMR R&D by coordination, cooperation and knowledge exchange", provides an overview of the challenges to and potential solutions for antibiotic discovery and development. To see the presentation slides, please click here. To view the event programme, please click here.